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1)  Database creation
New Psychoactive Substances (NPS) are constantly being developed as legal substitution of traditional drugs of abuse. Although the traditional drugs maintain popular, new drugs are regularly introduced, changing the drug market ceaselessly
[1]. Monitoring NPS and its consumption is challenging as these compounds are normally missed in routine drug analysis, users do often not exactly know what they consume and information available is limited of what is being sold. Furthermore,
very little information exists on metabolism of these newly introduced NPS [2]. This highlights the need of applying a strategic workflow making use of modern analytical techniques to face this novel public health safety challenge. The workflow
presented in this work consists of three stages: i) The creation of a database with around 200 NPS, including NPS recently reported to the National Early Warning Systems (EWS) of Spain and Italy and the EWS of the European Monitoring Center
for Drugs and Drug Addiction (EMCDDA). ii) The collection of urine samples of individuals suspected of drug consumption, pooled urine samples from festivals and urban wastewater samples. iii) The screening of NPS using ultra-high
performance liquid chromatography coupled to high resolution mass spectrometry with a hybrid quadrupole time-of-flight mass analyzer.
Although the database is under constant development, including NPS reported to be present in wastewaters around Europe, new compounds appearing in the market, as well as metabolites reported in the literature, the workflow applied
allowed the detection of several unchanged NPS in urine and wastewater samples, which indicates that consumption of some of these compounds is a reality. The absence of reference standards for several NPS found, as well as for some NPS
metabolites, made it unfeasible the full confirmation of some compounds in the urine/wastewater samples analyzed. However, accurate-mass full-spectrum data provided by HRMS allowed their detection / identification with high degree of
reliability. The subsequent acquisition of reference standards, when available, will allow the unequivocal confirmation of their identity.
[1] Reid, M. and Thomas, K. (2016), ‘New psychoactive substances: analysis and site-specific testing’, pp. 57–65 in Assessing illicit drugs in wastewater: advances in wastewater-based
drug epidemiology, EMCDDA Insights 22, Publications Office of the European Union, Luxembourg.
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 Collection of Urine samples of potential consumers:
o Emergency Rooms and Drug Addiction Treatment Departments: 
individual urine samples from suspect consumers
o Music festivals:
• Pooled urine samples from volunteers
• Pooled urine samples from portable toilets
 Collection of Urban Wastewater:
o Pooled Urban Wastewater collected during local festivities
> 900 samples from 6 
hospitals




INSTRUMENTATION (UHPLC- QTOF MS)SAMPLE TREATMENT SCREENING CRITERIA
SCREENING ANALYSIS
UHPLC (Acquity UHPLC, Waters)
Column: Cortecs® C18 2.7µm 2.1x100 mm 
Mobile phase: A: H2O 0.01 % HCOOH 
B: MeOH 0.01% HCOOH
Flow: 0.3 mL min-1
Volume  injection: 20 µL
QTOF MS (Xevo G2 QTOF, Waters)
ESI+ mode
Acquisition Mass range: 50 to 1000 m/z units
Sampling cone: 25 V
MSE Low Energy Function (LE): 4 eV  
High Energy Function (HE): 10-40 eV
Capillary voltage:    0.7 kV 
Source Temperature: 130 ºC
Gradient
0 min 10 % B
14-16 min 90 % B
16.1 min 10 % B
18 min 10 % B
Screening parameters [3]:




•Two ions (Q and q)
•Q mass error  < 5 ppm
•q mass error  < 5 ppm









•Two ions (Q and q)




•Expected ion (Q) present with mass error < 5 ppm
•Compatible isotopic pattern (Cl, Br…)
•One or more fragment ions (q),
- in agreement with data reported
- compatible with the chemical structure of the candidate 
(mass error < 5 ppm)
Confirmation required with reference 
standard
Individual urines from 
Hospitals
Pooled urines from Music 
Festivals
Urban Wastewater
















100 mL sample (pH 2)
Oasis MCX
(cationic exchange cartridge)








































































 Alert released in March 2010 by
EMCDDA [4]
 Submitted to control and criminal
penalties in EU in December 2010 [4]
 Found in Pooled 
Urine Sample from 
Music Festivals
4-MEC Standard




































 Health and Social risks assessed by
EMCDDA in April 2014 [5]
 Several intoxications across EU reported
in 2014 [5]
























Individual Urine Sample (Spiked with MXE 200ppb)
Rt = 4.09 min
(ΔRt > 0.2min with Std.)




















 A database containing more than 200 recently seized compounds was created based on the information provided by
different national and international authorities.
 Approximately 1000 samples were collected with an strategic sampling process in locations with high probability of
NPS consumption.
 A total of 19 NPS were found in urine samples from hospitals and music festivals and in urban wastewater.
 The majority of NPS detected were cathinones (62%) which agrees with reports of EMCDDA on NPS consumption.
 No synthetic cannabinoids were found. Probably, this was due to the fact that these type of compounds are highly




EWS from Spain and Italy
Seizures
Notifications






• Expected ion ([M+H]+) with mass error < 5ppm
• Fragments according with structure (and Std.) with < 5 ppm
• Isotope pattern
• Rt agreement with Std. (± 0.2min)
Urban Wastewater
Hospitals
Music Festivals
